Stroke Revisited: Dyslipidemia in Stroke

1. Front Matter

   Pages i-xiii

   PDF

2. Basic Science: Dyslipidemia and Stroke

   1. Front Matter

      Pages 1-1

      PDF

   2. Role of Dyslipidemia in Atherosclerosis

      • Akhlaq A. Farooqui

      Pages 3-14

   3. Effects of Dyslipidemia on the Cerebral Vessels

      • Chan-Hyuk Lee, Hyun Goo Kang

      Pages 15-20

3. Clinical Significance of Dyslipidemia in Stroke

   1. Front Matter

      Pages 21-21

      PDF

   2. Impact of Dyslipidemia on Ischemic Stroke

      • Yong-Jae Kim, Eung-Gyu Kim

      Pages 23-41

   3. Dyslipidemia and Hemorrhagic Stroke

      • Sung-Il Sohn

      Pages 43-54

   4. Clinical Biomarkers of Dyslipidemia

      • Hee-Kwon Park

      Pages 55-64

4. Treatment of Dyslipidemia in Stroke Patients

   1. Front Matter

      Pages 65-65

      PDF

   2. Therapeutic Lifestyle Modification

      • Gyeongsil Lee, Yun Hwan Oh, Seulggie Choi, Sang Min Park

      Pages 67-75

   3. Statins

      • Minwoo Lee, Byung-Chul Lee

      Pages 77-89

   4. Ezetimibe

      • Min Kyoung Kang

      Pages 91-101

   5. Fibrate and Niacin

      • Yang-Ha Hwang

      Pages 103-110

   6. Fish Oils

      • Jae-Myung Kim, Man-Seok Park

      Pages 111-123

   7. PCSK9 Inhibiting Monoclonal Antibodies

      • Zain Ahmed, Prerak Juthani, Megan Lee, Nihar R. Desai

      Pages 125-133

   8. PCSK9 Inhibiting siRNA

      • R. Scott Wright

      Pages 135-143

   9. Understanding of Clinical Practice Guidelines for Dyslipidemia

      • Eun-Jung Rhee

      Pages 145-151

5. Management of Dyslipidemia in Clinical Practice of Stroke

   1. Front Matter

      Pages 153-153

      PDF

   2. Practical Management of Dyslipidemia in Stroke Patients

      • Jong S. Kim

      Pages 155-163

   3. Practical Dyslipidemia Management in Stroke-Specific Situations

      • Jin-Man Jung, Woo-Keun Seo

      Pages 165-172

This book presents state of the art knowledge on dyslipidemia in stroke, covering both basic and clinical aspects in detail. The focus is in particular on two major themes: the clinical significance of dyslipidemia in stroke and the treatment of dyslipidemia in stroke patients. Readers will find up-to-date information on lipid metabolism, biomarkers, and advances in treatment options, including novel biologic drugs. Specific management considerations and pitfalls are also discussed. The individual components of pathophysiology, treatment, and key issues are addressed with the aid of complementary illustrations that facilitate understanding of practical aspects and enable the reader to retrieve fundamental information quickly. This book is timely in bringing together within one volume the most important current knowledge on dyslipidemia in stroke. It will be invaluable for stroke physicians, pharmacists, and students seeking to acquire up-to-date knowledge.

• dyslipidemia
• stroke
• atherosclerosis
• cardiovascular disease
• biomarker

• Department of Neurology, Seoul National University Hospital, Seoul, Korea (Republic of)

  Seung-Hoon Lee

• Department of Neurology, Uijeongbu Eulji Medical Center, Gyeonggi, Korea (Republic of)

  Min Kyoung Kang

Seung-Hoon Lee, MD
Professor, Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea
Chairman, Korean Cerebrovascular Research Institute, Republic of Korea

Min Kyoung Kang, MD

Department of Neurology, Uijeongbu Eulji Medical Center

Gyeonggi, Republic of Korea

Policies and ethics